Reference
Rafiullah, et al. Duodenal perforation secondary to erlotinib therapy in a patient with non-small cell lung cancer. Wisconsin Medical Journal 116: 34-36, No. 1, Feb 2017. Available from: URL: https://www.researchgate.net/publication/315896617_Duodenal_perforation_secondary_to_erlotinib_therapy_in_a_patient_with_non-small_cell_lung_cancer - USA
Rights and permissions
About this article
Cite this article
Erlotinib. Reactions Weekly 1650, 132 (2017). https://doi.org/10.1007/s40278-017-29664-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-29664-x